CH605672A5 - - Google Patents

Info

Publication number
CH605672A5
CH605672A5 CH1838971A CH1838971A CH605672A5 CH 605672 A5 CH605672 A5 CH 605672A5 CH 1838971 A CH1838971 A CH 1838971A CH 1838971 A CH1838971 A CH 1838971A CH 605672 A5 CH605672 A5 CH 605672A5
Authority
CH
Switzerland
Application number
CH1838971A
Inventor
Victor Assad Najjar
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of CH605672A5 publication Critical patent/CH605672A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1019Tetrapeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1024Tetrapeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CH1838971A 1970-12-16 1971-12-16 CH605672A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9889070A 1970-12-16 1970-12-16

Publications (1)

Publication Number Publication Date
CH605672A5 true CH605672A5 (en) 1978-10-13

Family

ID=22271422

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1838971A CH605672A5 (en) 1970-12-16 1971-12-16

Country Status (7)

Country Link
US (1) US3778426A (en)
JP (1) JPS6053040B1 (en)
CA (1) CA999851A (en)
CH (1) CH605672A5 (en)
DE (1) DE2124003C2 (en)
FR (1) FR2118134B1 (en)
GB (1) GB1364497A (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966701A (en) * 1973-11-07 1976-06-29 The Dow Chemical Company Fibrinogen peptide derivatives
US4001199A (en) * 1974-03-26 1977-01-04 Takeda Chemical Industries, Ltd. Novel polypeptides useful for treating diabetes and hypercholesteremia
US4073890A (en) * 1974-03-26 1978-02-14 Takeda Chemical Industries, Ltd. Novel polypeptides
US4016259A (en) * 1974-07-26 1977-04-05 Research Corporation Contraceptive polypeptides
SE407058B (en) * 1974-12-05 1979-03-12 Kabi Ab NEW CHROMOGENA ENZYME SUBSTRATE FOR SERINE PROTEASES
DE2602443A1 (en) * 1975-04-04 1976-10-21 Univ California BIOLOGICALLY ACTIVE POLYPEPTIDES
US4061625A (en) * 1975-07-11 1977-12-06 Ab Kabi Novel chromogenic thrombin substrates
US4169015A (en) * 1975-07-11 1979-09-25 Ab Kabi Novel chromogenic thrombin substrates
US4181717A (en) * 1978-09-07 1980-01-01 Research Corporation Ovulation enhancing peptides
IT8021120A0 (en) 1979-04-02 1980-04-01 Inst Organicheskogo Sinteza Ak CYCLIC ANALOGUE OF THE NATURAL PEPTIDE THAT STIMULATES PHAGOCYTOSIS: THREONYL-CYCLE (N-LYSYL-PROLYL-ARGINYL).
US4683292A (en) * 1983-08-12 1987-07-28 Immunetech, Inc. Immunotherapeutic polypeptide agents which bind to lymphocyte immunoglobulin FC receptors
US4752601A (en) * 1983-08-12 1988-06-21 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin FC receptors
US4585757A (en) * 1984-07-27 1986-04-29 Texas Tech University Health Sciences Center Hypotensive active peptides
IT1188646B (en) * 1986-04-09 1988-01-20 Ellem Ind Farmaceutica TRIPEPTIDE WITH IMMUNOSTIMULANT ACTIVITY
GB8807427D0 (en) * 1988-03-28 1988-05-05 National Biological Standards Board Peptides
JP2633369B2 (en) * 1988-03-28 1997-07-23 ブリティッシュ・テクノロジー・グループ・リミテッド peptide
IT1230712B (en) * 1989-02-10 1991-10-29 Sclavo Spa COMPOSITION FOR VACCINES
US5028593A (en) * 1989-08-15 1991-07-02 Board Of Regents, The University Of Texas System Tuftsin analogs
IT1232311B (en) * 1989-09-04 1992-01-28 Sclavo Spa PURIFICATION METHOD OF LOW MOLECULAR PEPTIDIC OR PSEUDO PEPTIDIC STRUCTURE COMPOUNDS.
GB9211668D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
US7666996B2 (en) * 2000-03-01 2010-02-23 Peptera Pharmaceuticals Ltd Casein derived peptides and uses thereof
HUP0500995A3 (en) * 2001-08-30 2008-09-29 Peptera Pharmaceuticals Ltd Casein derived peptides and uses thereof in therapy
WO2009033792A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent
RU2507212C3 (en) * 2012-03-28 2022-05-04 Общество С Ограниченной Ответственностью "Айвикс" METHOD FOR PRODUCING RECOMBINANT PEPTIDE AND PRODUCED PEPTIDE
CN104662034B (en) * 2013-05-28 2021-05-11 "Ivix"有限公司 Method for producing recombinant peptides and resulting peptides
RU2626002C1 (en) 2016-10-24 2017-07-21 Общество С Ограниченной Ответственностью "Айвикс" New group of peptides for treatment of female sexual dysfunction
JP2018118973A (en) * 2018-02-23 2018-08-02 アイビックス・リミテッドIvix Ltd. Method for producing recombinant peptide and resultant peptide

Also Published As

Publication number Publication date
DE2124003C2 (en) 1982-04-22
FR2118134A1 (en) 1972-07-28
FR2118134B1 (en) 1975-10-10
GB1364497A (en) 1974-08-21
DE2124003A1 (en) 1972-06-22
CA999851A (en) 1976-11-16
JPS6053040B1 (en) 1985-11-22
US3778426A (en) 1973-12-11

Similar Documents

Publication Publication Date Title
FR2118134B1 (en)
AR204384A1 (en)
ATA96471A (en)
AU1146470A (en)
AU1473870A (en)
AU428055B2 (en)
AU1517670A (en)
AU1326870A (en)
AU1336970A (en)
AU1716970A (en)
AR195465A1 (en)
AU1343870A (en)
AU1689770A (en)
AU1832970A (en)
AU1189670A (en)
AU1235770A (en)
AU1247570A (en)
AU1277070A (en)
AU1789870A (en)
AU1086670A (en)
AU1328670A (en)
AU1083170A (en)
AU1064870A (en)
ATA672271A (en)
AU1004470A (en)

Legal Events

Date Code Title Description
PL Patent ceased